Systems Toxicology: The Future of Risk Assessment

International Journal of Toxicology

Volumn 34, Issue 4, 2015, Pages 346-348

  Sauer, John Michael ^a   Hartung, Thomas ^b   Leist, Marcel ^c   Knudsen, Thomas B ^d   Hoeng, Julia ^e   Hayes, A Wallace ^f,g  

^a CRITICAL PATH INSTITUTE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF KONSTANZ   (Germany)

^d U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^e PHILIP MORRIS PRODUCTS S A   (Switzerland)

^f HARVARD UNIVERSITY   (United States)

^g UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

risk assessment; systems toxicology

Indexed keywords

ARTICLE; CLINICAL RESEARCH; COMPUTER MODEL; RISK ASSESSMENT; RISK MANAGEMENT; SYSTEMS TOXICOLOGY; TOXICOLOGY; ANIMAL; DANGEROUS GOODS; DISEASE MODEL; ENVIRONMENTAL EXPOSURE; HUMAN; ORGANIZATION; TOXICITY;

DANGEROUS GOODS; XENOBIOTIC AGENT;

ANIMALS; CONGRESSES AS TOPIC; DISEASE MODELS, ANIMAL; ENVIRONMENTAL EXPOSURE; HAZARDOUS SUBSTANCES; HUMANS; RISK ASSESSMENT; TOXICOLOGY; XENOBIOTICS;

EID: 84937496036     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1177/1091581815576551     Document Type: Article

References (16)

1. Hartung T, van Vliet E, Jaworska J,. 2012. Systems toxicology. ALTEX. 2012; 29 (2): 119-128.
2. Sturla SJ, Boobis AR, FitzGerald RE,. Systems toxicology: from basic research to risk assessment. Chem Res Toxicol. 2014; 27 (3): 314-329.
3. Coecke S, Balls M, Bowe G,. Guidance on good cell culture practice. Altern Lab Anim. 2005; 33 (3): 261-287.
4. Hartung T, Zurlo J,. Alternative approaches for medical countermeasures to biological and chemical terrorism and warfare. ALTEX. 2012; 29 (3): 251-260.
5. Andersen M, Betts K, Dragan Y,. 2014. Developing microphysiological systems for use as regulatory tools-challenges and opportunities. ALTEX. 2014; 31 (3): 364-367.
6. Kleensang A, Maertens A, Rosenberg M,. Pathways of toxicity. ALTEX. 2014; 31 (1): 53-61.
7. Hartung T,. Look back in anger-what clinical studies tell us about preclinical work. ALTEX. 2013; 30 (3): 275-291.
8. Hartung T, Luechtefeld T, Maertens A, Kleensang A., 2013. Integrated testing strategies for safety assessments. ALTEX. 2013; 30 (1): 3-18.
9. Krug AK, Gutbier S, Zhao L,. Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP(+). Cell Death Dis. 2014; 5: e1222.
10. Kleinstreuer N, Dix D, Rountree M,. A computational model predicting disruption of blood vessel development. PLoS Comput Biol. 2013; 9 (4): e1002996. doi:10.1371/journal.pcbi.1002996.
11. Hoeng J, Deehan R, Pratt D,. A network-based approach to quantify the impact of biologically active substances. Drug Discov Today. 2012; 17 (9-10): 413-418.
12. Kogel U, Schlage WK, Martin F,. A 28-day rat inhalation study with an integrated molecular toxicology endpoint demonstrates reduced exposure effects for a prototypic modified risk tobacco product compared with conventional cigarettes. Food Chem Toxicol. 2014; 68: 204-217.
13. Martin F, Sewer A, Talikka M, Xiang Y, Hoeng J, Peitsch MC,. Quantification of biological network perturbations for mechanistic insight and diagnostics using two-layer causal models. BMC Bioinformatics, 2014; 15: 238.
14. Mathis C, Poussin C, Weisensee D,. Human bronchial epithelial cells exposed in vitro to cigarette smoke at the air-liquid interface resemble bronchial epithelium from human smokers. Am J Physiol Lung Cell Mol Physiol. 2013; 304 (7): L489-L503.
15. Iskandar AR, Martin F, Talikka M,. Systems approaches evaluating the perturbation of xenobiotic metabolism in response to cigarette smoke exposure in nasal and bronchial tissues. Biomed Res Int. 2013; 2013: 512086.
16. Hoeng J, Talikka M, Martin F,. Case study: the role of mechanistic network models in systems toxicology. Drug Discov Today. 2014; 19 (2): 183-192.